Mo H[au] - Search Results

Year	Number of Results
1960	1
1963	1
1965	1
1966	1
1981	1
1986	2
1989	1
1990	1
1991	3
1993	3
1994	4
1995	3
1996	3
1997	4
1998	5
1999	10
2000	8
2001	14
2002	11
2003	10
2004	14
2005	16
2006	22
2007	25
2008	24
2009	22
2010	28
2011	41
2012	50
2013	50
2014	43
2015	69
2016	106
2017	80
2018	99
2019	102
2020	103
2021	132
2022	161
2023	112

1

Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer.

Zhang Y, Chen H, Mo H, Hu X, Gao R, Zhao Y, Liu B, Niu L, Sun X, Yu X, Wang Y, Chang Q, Gong T, Guan X, Hu T, Qian T, Xu B, Ma F, Zhang Z, Liu Z. Zhang Y, et al. Among authors: mo h. Cancer Cell. 2021 Dec 13;39(12):1578-1593.e8. doi: 10.1016/j.ccell.2021.09.010. Epub 2021 Oct 14. Cancer Cell. 2021. PMID: 34653365 Free article.

2

Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma.

Zhang Y, Chen L, Hu GQ, Zhang N, Zhu XD, Yang KY, Jin F, Shi M, Chen YP, Hu WH, Cheng ZB, Wang SY, Tian Y, Wang XC, Sun Y, Li JG, Li WF, Li YH, Tang LL, Mao YP, Zhou GQ, Sun R, Liu X, Guo R, Long GX, Liang SQ, Li L, Huang J, Long JH, Zang J, Liu QD, Zou L, Su QF, Zheng BM, Xiao Y, Guo Y, Han F, Mo HY, Lv JW, Du XJ, Xu C, Liu N, Li YQ, Chua MLK, Xie FY, Sun Y, Ma J. Zhang Y, et al. Among authors: mo hy. N Engl J Med. 2019 Sep 19;381(12):1124-1135. doi: 10.1056/NEJMoa1905287. Epub 2019 May 31. N Engl J Med. 2019. PMID: 31150573 Clinical Trial.

3

Tumor buster - where will the CAR-T cell therapy 'missile' go?

Qu C, Zhang H, Cao H, Tang L, Mo H, Liu F, Zhang L, Yi Z, Long L, Yan L, Wang Z, Zhang N, Luo P, Zhang J, Liu Z, Ye W, Liu Z, Cheng Q. Qu C, et al. Among authors: mo h. Mol Cancer. 2022 Oct 19;21(1):201. doi: 10.1186/s12943-022-01669-8. Mol Cancer. 2022. PMID: 36261831 Free PMC article. Review.

4

Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer.

Luo H, Zhao Q, Wei W, Zheng L, Yi S, Li G, Wang W, Sheng H, Pu H, Mo H, Zuo Z, Liu Z, Li C, Xie C, Zeng Z, Li W, Hao X, Liu Y, Cao S, Liu W, Gibson S, Zhang K, Xu G, Xu RH. Luo H, et al. Among authors: mo h. Sci Transl Med. 2020 Jan 1;12(524):eaax7533. doi: 10.1126/scitranslmed.aax7533. Sci Transl Med. 2020. PMID: 31894106

5

Methionine deficiency facilitates antitumour immunity by altering m⁶A methylation of immune checkpoint transcripts.

Li T, Tan YT, Chen YX, Zheng XJ, Wang W, Liao K, Mo HY, Lin J, Yang W, Piao HL, Xu RH, Ju HQ. Li T, et al. Among authors: mo hy. Gut. 2023 Mar;72(3):501-511. doi: 10.1136/gutjnl-2022-326928. Epub 2022 Jul 8. Gut. 2023. PMID: 35803704 Free PMC article.

6

A single-cell atlas of liver metastases of colorectal cancer reveals reprogramming of the tumor microenvironment in response to preoperative chemotherapy.

Che LH, Liu JW, Huo JP, Luo R, Xu RM, He C, Li YQ, Zhou AJ, Huang P, Chen YY, Ni W, Zhou YX, Liu YY, Li HY, Zhou R, Mo H, Li JM. Che LH, et al. Among authors: mo h. Cell Discov. 2021 Sep 7;7(1):80. doi: 10.1038/s41421-021-00312-y. Cell Discov. 2021. PMID: 34489408 Free PMC article.

7

Final Overall Survival Analysis of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma: A Multicenter, Randomized Phase III Trial.

Zhang Y, Chen L, Hu GQ, Zhang N, Zhu XD, Yang KY, Jin F, Shi M, Chen YP, Hu WH, Cheng ZB, Wang SY, Tian Y, Wang XC, Sun Y, Li JG, Li WF, Li YH, Mao YP, Zhou GQ, Sun R, Liu X, Guo R, Long GX, Liang SQ, Li L, Huang J, Long JH, Zang J, Liu QD, Zou L, Su QF, Zheng BM, Xiao Y, Guo Y, Han F, Mo HY, Lv JW, Du XJ, Xu C, Liu N, Li YQ, Xie FY, Sun Y, Ma J, Tang LL. Zhang Y, et al. Among authors: mo hy. J Clin Oncol. 2022 Aug 1;40(22):2420-2425. doi: 10.1200/JCO.22.00327. Epub 2022 Jun 16. J Clin Oncol. 2022. PMID: 35709465 Clinical Trial.

8

Single-cell RNA sequencing to identify cellular heterogeneity and targets in cardiovascular diseases: from bench to bedside.

Xu X, Hua X, Mo H, Hu S, Song J. Xu X, et al. Among authors: mo h. Basic Res Cardiol. 2023 Feb 7;118(1):7. doi: 10.1007/s00395-022-00972-1. Basic Res Cardiol. 2023. PMID: 36750503 Review.

9

The Macrophage-Associated LncRNA MALR Facilitates ILF3 Liquid-Liquid Phase Separation to Promote HIF1α Signaling in Esophageal Cancer.

Liu J, Liu ZX, Li JJ, Zeng ZL, Wang JH, Luo XJ, Wong CW, Zheng JB, Pu HY, Mo HY, Sheng H, Wu QN, Li H, Wan G, Li B, Wang DS, Xu RH, Ju HQ. Liu J, et al. Among authors: mo hy. Cancer Res. 2023 May 2;83(9):1476-1489. doi: 10.1158/0008-5472.CAN-22-1922. Cancer Res. 2023. PMID: 36264156

10

Targeting cholesterol biosynthesis promotes anti-tumor immunity by inhibiting long noncoding RNA SNHG29-mediated YAP activation.

Ni W, Mo H, Liu Y, Xu Y, Qin C, Zhou Y, Li Y, Li Y, Zhou A, Yao S, Zhou R, Huo J, Che L, Li J. Ni W, et al. Among authors: mo h. Mol Ther. 2021 Oct 6;29(10):2995-3010. doi: 10.1016/j.ymthe.2021.05.012. Epub 2021 May 14. Mol Ther. 2021. PMID: 33992804 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

1,219 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

1,219 results

Results by year